Hemorrhoid Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Suppository, Sprays, Creams & Ointments, Others), By Application (Hospital Pharmacy, Drug Stores & Retail Pharmacy, Online Pharmacy), Regional Insights and Forecast to 2035

Hemorrhoid Treatment Market Overview

Hemorrhoid Treatment Market size is projected at USD 1137.53 million in 2026 and is anticipated to reach USD 1981.63 million by 2035, registering a CAGR of 6.36%.

The Hemorrhoid Treatment Market is expanding steadily due to the rising global prevalence of anorectal disorders, sedentary lifestyles, and aging populations. Hemorrhoids affect nearly 50% of adults over the age of 50 worldwide, with increasing incidence among younger demographics due to poor dietary habits and prolonged sitting. The Hemorrhoid Treatment Market Analysis highlights growing demand for minimally invasive procedures, including rubber band ligation and infrared coagulation, which account for over 60% of outpatient treatments. Additionally, topical medications and oral therapies continue to dominate initial treatment approaches, contributing significantly to Hemorrhoid Treatment Market Size and overall Hemorrhoid Treatment Market Growth across healthcare systems.

In the USA, hemorrhoids impact approximately 1 in 20 individuals annually, with nearly 10 million cases reported each year. Around 75% of Americans experience hemorrhoids at some point in their lifetime, increasing demand for effective treatment options. The Hemorrhoid Treatment Market in the USA is driven by strong healthcare infrastructure and high awareness levels. Outpatient procedures account for over 65% of treatments, while prescription medications contribute to nearly 40% of total interventions. The growing elderly population, which exceeds 55 million individuals, further strengthens Hemorrhoid Treatment Market Trends and Hemorrhoid Treatment Market Opportunities in the region.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Over 65% increase in sedentary lifestyle cases, 58% rise in obesity-related conditions, 62% higher gastrointestinal disorder prevalence, 55% increased aging population impact, and 60% demand growth for minimally invasive hemorrhoid treatment procedures globally.
• Major Market Restraint: Around 48% patient hesitation due to social stigma, 42% underdiagnosis rates, 50% preference for home remedies, 46% limited awareness in developing regions, and 44% delay in clinical consultations affecting treatment adoption.
• Emerging Trends: Approximately 63% adoption of minimally invasive techniques, 57% increase in outpatient procedures, 52% preference for laser treatments, 49% digital health consultation growth, and 55% shift toward non-surgical hemorrhoid treatment solutions.
• Regional Leadership: North America holds nearly 38% market share, Europe contributes 30%, Asia-Pacific accounts for 22%, Latin America captures 6%, and Middle East & Africa represent 4% of Hemorrhoid Treatment Market Share globally.
• Competitive Landscape: Around 45% market consolidation among top players, 40% investment in R&D, 50% expansion in product portfolios, 42% strategic collaborations, and 47% focus on minimally invasive device innovation shaping industry competition.
• Market Segmentation: Medical treatments dominate with 54%, surgical procedures hold 28%, minimally invasive techniques account for 60% within procedures, hospital usage reaches 52%, and ambulatory centers contribute 48% of total demand.
• Recent Development: Nearly 58% increase in device approvals, 52% rise in laser-based treatment adoption, 49% growth in teleconsultation usage, 55% expansion in outpatient care centers, and 50% innovation in pain-free treatment technologies.

Hemorrhoid Treatment Market Latest Trends

The Hemorrhoid Treatment Market Trends are strongly influenced by technological advancements and patient preference for less invasive procedures. Minimally invasive techniques such as laser therapy and infrared coagulation now account for more than 60% of procedures performed globally. These treatments offer reduced recovery times, with patients resuming normal activities within 24 to 48 hours. Additionally, the Hemorrhoid Treatment Market Insights reveal a 55% increase in demand for outpatient procedures due to cost-effectiveness and convenience.

Another notable trend in the Hemorrhoid Treatment Industry Analysis is the increasing adoption of telemedicine for diagnosis and follow-up care, which has grown by nearly 50% in recent years. Pharmaceutical innovations, including improved topical formulations and oral medications, have enhanced symptom management, contributing to 45% of initial treatments. The Hemorrhoid Treatment Market Forecast also highlights growing investments in advanced surgical devices, particularly in emerging economies, where healthcare infrastructure is rapidly improving, supporting broader access to treatment solutions.

Hemorrhoid Treatment Market Dynamics

DRIVER

"Rising prevalence of lifestyle-related disorders"

The Hemorrhoid Treatment Market Growth is primarily driven by the increasing prevalence of lifestyle-related conditions such as obesity, chronic constipation, and sedentary behavior. Studies indicate that over 60% of adults globally experience digestive health issues linked to poor diet and inactivity. Nearly 58% of working professionals spend more than 8 hours sitting daily, significantly increasing hemorrhoid risk. Additionally, the aging population contributes heavily, with individuals above 50 years representing nearly 50% of diagnosed cases. This growing patient pool directly boosts demand for both medical and procedural treatments, strengthening Hemorrhoid Treatment Market Size and expanding Hemorrhoid Treatment Market Opportunities across healthcare providers.

RESTRAINTS

"Social stigma and delayed diagnosis"

A significant restraint in the Hemorrhoid Treatment Market Analysis is the persistent social stigma associated with anorectal conditions, leading to delayed diagnosis and treatment. Approximately 48% of patients avoid seeking medical help due to embarrassment, while nearly 42% rely on self-medication or home remedies. This delay often results in complications requiring advanced procedures, increasing treatment complexity. Furthermore, awareness levels remain low in developing regions, where nearly 46% of cases go undiagnosed. These factors limit early intervention and reduce the adoption rate of professional medical treatments, affecting overall Hemorrhoid Treatment Market Growth and slowing industry expansion.

OPPORTUNITY

"Advancements in minimally invasive technologies"

The Hemorrhoid Treatment Market Opportunities are expanding due to rapid advancements in minimally invasive technologies. Procedures such as laser hemorrhoidoplasty and Doppler-guided hemorrhoidal artery ligation have seen adoption rates exceeding 55% in developed healthcare systems. These treatments reduce pain by nearly 60% and shorten recovery time by up to 70%, making them highly attractive to patients. Additionally, healthcare providers are increasingly investing in outpatient facilities, which have grown by 50% in recent years. Emerging markets are also witnessing a surge in medical device adoption, creating strong growth potential and enhancing Hemorrhoid Treatment Market Outlook for innovative solutions.

CHALLENGE

"High treatment costs and limited access"

One of the major challenges in the Hemorrhoid Treatment Market is the high cost associated with advanced treatment procedures and limited access in low-income regions. Minimally invasive surgeries can cost up to 40% more than conventional treatments, restricting affordability for a large population segment. Additionally, nearly 45% of rural healthcare facilities lack access to advanced medical equipment and trained professionals. Insurance coverage limitations also impact patient decisions, with around 38% of individuals opting for delayed or alternative treatments. These barriers hinder widespread adoption and create disparities in Hemorrhoid Treatment Market Share across regions, affecting overall industry penetration.

Hemorrhoid Treatment Market Segmentation

The Hemorrhoid Treatment Market Segmentation is categorized by type and application, reflecting diverse treatment approaches and distribution channels. By type, creams & ointments dominate with over 45% usage due to ease of application, followed by suppositories at nearly 25%, sprays at around 15%, and other treatments comprising 15%. By application, drug stores & retail pharmacies lead with approximately 50% share, hospital pharmacies account for nearly 30%, and online pharmacies contribute close to 20%, driven by digital healthcare adoption and accessibility.

Download Free Sample to learn more about this report.

BY TYPE

Suppository: Suppositories represent a significant segment in the Hemorrhoid Treatment Market, accounting for approximately 25% of total treatment usage. These rectally administered medications are highly effective for internal hemorrhoids, delivering targeted relief directly to affected tissues. Clinical observations indicate that nearly 60% of patients with moderate internal hemorrhoids prefer suppositories due to their fast-acting formulation and improved absorption rates compared to oral medications. Additionally, suppositories are often recommended in over 55% of hospital-prescribed cases where localized anti-inflammatory action is required. Their usage is particularly high among patients aged above 50, who represent nearly 50% of hemorrhoid cases globally. Furthermore, around 48% of chronic sufferers rely on suppositories for recurring symptom management, reinforcing their importance in the Hemorrhoid Treatment Market Analysis and contributing steadily to Hemorrhoid Treatment Market Growth.

Sprays: Sprays account for nearly 15% of the Hemorrhoid Treatment Market Share and are gaining traction due to their hygienic, non-contact application method. Studies show that approximately 52% of younger patients prefer sprays for convenience and ease of use, especially in early-stage hemorrhoid conditions. Sprays are commonly used for external hemorrhoids and provide immediate soothing effects, with nearly 58% of users reporting faster relief from itching and irritation. Additionally, about 45% of over-the-counter hemorrhoid products now include spray-based formulations, reflecting increasing consumer demand. Their portability and discreet usage make them popular among working professionals, who represent around 60% of spray users. As innovation in topical delivery systems continues, sprays are expected to expand their footprint within the Hemorrhoid Treatment Market Trends and contribute to broader product diversification.

Creams & Ointments: Creams & ointments dominate the Hemorrhoid Treatment Market Size, accounting for over 45% of total product usage globally. These topical treatments are widely preferred due to their ease of application, affordability, and immediate symptom relief. Approximately 70% of patients with mild to moderate hemorrhoids use creams as a first-line treatment. Additionally, nearly 65% of over-the-counter hemorrhoid medications are available in cream or ointment form, highlighting their accessibility. These products are particularly effective for reducing inflammation, itching, and pain, with around 62% of users reporting symptom improvement within a short duration. The segment also benefits from strong presence in retail pharmacies, where nearly 55% of purchases occur. Increasing awareness and self-care practices continue to drive demand, reinforcing creams & ointments as a cornerstone in Hemorrhoid Treatment Market Insights.

Others: The “Others” category, contributing approximately 15% to the Hemorrhoid Treatment Market, includes oral medications, wipes, and advanced procedural aids. Oral treatments are used by nearly 40% of patients as supportive therapy, particularly for improving blood circulation and reducing inflammation. Medicated wipes have gained popularity, with around 35% of patients using them for hygiene and symptom relief. Additionally, alternative treatments such as herbal formulations and dietary supplements are adopted by nearly 30% of individuals seeking non-invasive options. This segment is also influenced by increasing interest in preventive care, with about 50% of patients incorporating lifestyle and dietary adjustments alongside treatment. Continuous product innovation and growing consumer awareness are expanding this segment’s contribution to Hemorrhoid Treatment Market Opportunities and supporting its steady growth.

BY APPLICATION

Hospital Pharmacy: Hospital pharmacies hold approximately 30% share in the Hemorrhoid Treatment Market, driven by the high volume of prescription-based treatments and surgical interventions. Nearly 65% of patients undergoing advanced procedures such as hemorrhoidectomy or minimally invasive therapies receive medications through hospital pharmacies. These facilities are critical for managing severe and complicated cases, which account for around 35% of total diagnoses. Additionally, hospital pharmacies ensure access to specialized drugs and post-operative care medications, with nearly 55% of patients relying on them for follow-up treatment. The presence of trained healthcare professionals further enhances patient trust, contributing to higher adoption rates. Hospitals also play a vital role in educating patients, with approximately 50% of individuals receiving guidance on long-term management. This segment remains essential for complex treatment pathways within the Hemorrhoid Treatment Market Analysis.

Drug Stores & Retail Pharmacy: Drug stores and retail pharmacies dominate the Hemorrhoid Treatment Market Share with nearly 50% contribution, owing to widespread availability and accessibility of over-the-counter products. Approximately 70% of patients with mild symptoms prefer purchasing treatments directly from retail outlets without requiring prescriptions. These pharmacies offer a wide range of creams, ointments, and sprays, accounting for nearly 65% of product sales. Additionally, around 60% of urban consumers rely on retail pharmacies for immediate symptom relief solutions. Pharmacist recommendations influence nearly 55% of purchasing decisions, highlighting the importance of in-store guidance. The segment also benefits from strong distribution networks, ensuring product availability in both urban and semi-urban areas. As self-medication trends continue to rise, retail pharmacies remain a key driver of Hemorrhoid Treatment Market Growth.

Online Pharmacy: Online pharmacies account for approximately 20% of the Hemorrhoid Treatment Market and are rapidly expanding due to increasing digital adoption. Nearly 58% of consumers prefer online platforms for privacy and convenience, particularly for sensitive conditions like hemorrhoids. The availability of home delivery services has increased usage by around 52%, especially among younger demographics and urban populations. Additionally, online pharmacies provide access to a broader range of products, with nearly 45% of users exploring multiple treatment options before purchase. Discount offers and subscription-based models influence approximately 50% of buying behavior. Telemedicine integration has further boosted this segment, with around 48% of patients consulting healthcare professionals online before purchasing medications. This digital transformation is reshaping Hemorrhoid Treatment Market Trends and enhancing accessibility across regions.

Hemorrhoid Treatment Market Regional Outlook

The Hemorrhoid Treatment Market Regional Outlook demonstrates a diversified global distribution, with North America leading at approximately 38% share, followed by Europe at nearly 30%, Asia-Pacific contributing around 22%, and Middle East & Africa holding close to 10% combined. Regional performance is influenced by healthcare infrastructure, awareness levels, and lifestyle-related disease prevalence. Developed regions account for over 65% of total procedures due to higher diagnosis rates, while emerging economies are witnessing nearly 55% growth in treatment adoption driven by improving healthcare access and increasing patient awareness.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America dominates the Hemorrhoid Treatment Market Share with approximately 38% contribution, supported by advanced healthcare infrastructure and high awareness levels. Nearly 75% of adults in the region experience hemorrhoids at some point, driving consistent demand for treatment solutions. The United States accounts for over 80% of the regional share, with more than 65% of treatments performed in outpatient settings. Minimally invasive procedures represent around 60% of total interventions, reflecting patient preference for quick recovery options. Additionally, nearly 70% of patients opt for over-the-counter medications as first-line treatment. The region also benefits from a strong presence of key pharmaceutical and medical device companies, contributing to nearly 55% of product innovations globally. High insurance coverage, reaching close to 68% of the population, further supports treatment accessibility and strengthens North America's leadership in the Hemorrhoid Treatment Market Analysis.

EUROPE

Europe holds approximately 30% of the Hemorrhoid Treatment Market Share, driven by well-established healthcare systems and increasing prevalence of gastrointestinal disorders. Around 60% of adults in Europe report experiencing hemorrhoid-related symptoms, with higher incidence among individuals aged above 50, who represent nearly 52% of cases. Countries such as Germany, France, and the United Kingdom collectively contribute over 65% of the regional demand. Minimally invasive procedures account for nearly 58% of treatments, while pharmaceutical solutions represent around 62% of initial care approaches. Additionally, public healthcare coverage reaches approximately 70% of the population, ensuring widespread access to treatment. Preventive healthcare awareness campaigns have increased diagnosis rates by nearly 45%, supporting steady growth in the Hemorrhoid Treatment Market Insights across the region.

ASIA-PACIFIC

Asia-Pacific accounts for nearly 22% of the Hemorrhoid Treatment Market Share and is emerging as a high-potential region due to its large population base and increasing healthcare investments. Approximately 50% of the adult population in urban areas reports symptoms related to hemorrhoids, driven by sedentary lifestyles and dietary patterns. Countries such as China, India, and Japan contribute over 70% of the regional demand. The adoption of minimally invasive treatments has increased by nearly 55%, while traditional and herbal remedies remain popular among approximately 40% of patients. Healthcare infrastructure improvements have expanded access to treatment for nearly 48% of the population in developing economies. Additionally, rising awareness and digital healthcare penetration, growing by around 50%, are accelerating the Hemorrhoid Treatment Market Growth in the region.

MIDDLE EAST & AFRICA

The Middle East & Africa region contributes close to 10% of the Hemorrhoid Treatment Market Share, with gradual improvements in healthcare access and awareness. Approximately 45% of the population experiences hemorrhoid symptoms, though diagnosis rates remain lower compared to developed regions. Urban areas account for nearly 60% of treated cases due to better healthcare facilities. Minimally invasive procedures are adopted in around 40% of cases, while traditional treatments still dominate nearly 50% of patient preferences. Government healthcare initiatives have improved access for approximately 42% of the population, supporting gradual market expansion. Additionally, increasing investments in healthcare infrastructure, growing by nearly 48%, are expected to enhance treatment availability and strengthen the Hemorrhoid Treatment Market Outlook across the region.

List of Key Hemorrhoid Treatment Market Companies

• Pfizer
• Ranbaxy
• Himalaya
• Astra zeneca
• Glenmark pharmaceuticals
• Glaxosmithkline plc.
• SURKON MEDICAL CO.,LTD.
• Jiangsu Kangjin Medical Instrument Co.,Ltd.
• LocaMed Limited
• Reach surgical
• Ultroid
• Sklar Surgical Instruments
• Cook
• Medline Industries, Inc.

Top Two Companies with Highest Share

• Pfizer: Holds nearly 18% share driven by 65% product reach and 60% adoption in prescription hemorrhoid treatment therapies globally.
• Glaxosmithkline plc.: Accounts for approximately 15% share supported by 58% consumer trust and 55% presence in over-the-counter hemorrhoid solutions.

Investment Analysis and Opportunities

The Hemorrhoid Treatment Market is witnessing strong investment activity driven by rising demand for minimally invasive procedures and advanced pharmaceutical solutions. Approximately 60% of healthcare investors are focusing on device innovation, particularly laser-based and non-surgical treatment technologies. Investments in outpatient care centers have increased by nearly 55%, reflecting the growing preference for cost-effective and quick recovery solutions. Additionally, around 50% of funding is directed toward expanding healthcare infrastructure in emerging economies, where access to treatment has improved for nearly 48% of the population.

Opportunities in the Hemorrhoid Treatment Market are further supported by increasing digital health adoption, which has grown by approximately 52%, enabling remote consultations and improved patient management. Nearly 58% of pharmaceutical companies are investing in new formulations to enhance treatment efficiency and patient comfort. Preventive healthcare initiatives have also gained traction, influencing around 45% of patients to seek early diagnosis and treatment. These factors collectively create a favorable environment for investors, strengthening Hemorrhoid Treatment Market Opportunities and expanding global market penetration.

New Products Development

New product development in the Hemorrhoid Treatment Market is driven by technological advancements and evolving patient preferences. Nearly 62% of manufacturers are focusing on minimally invasive treatment devices, including laser and infrared-based solutions that reduce recovery time by up to 70%. Additionally, around 55% of pharmaceutical companies are introducing advanced topical formulations with improved absorption rates and faster symptom relief. Combination therapies, integrating anti-inflammatory and anesthetic agents, have seen adoption increase by approximately 50%, enhancing treatment effectiveness.

The development of user-friendly products such as sprays and medicated wipes has grown by nearly 48%, catering to patients seeking convenient and hygienic solutions. Furthermore, digital integration in healthcare has led to the introduction of smart diagnostic tools, adopted by around 45% of healthcare providers. These innovations are supported by continuous research and development efforts, with nearly 58% of companies prioritizing product differentiation. As a result, new product launches are significantly shaping Hemorrhoid Treatment Market Trends and driving competitive advantage across the industry.

Five Recent Developments

• Advanced Laser Technology Launch: In 2025, manufacturers introduced laser-based hemorrhoid treatment devices with nearly 65% improved precision and 60% reduction in post-procedure pain, enhancing patient outcomes and increasing adoption across specialized healthcare centers globally.
• Expansion of Outpatient Treatment Centers: Around 55% increase in outpatient facility expansion was observed in 2025, enabling faster treatment access and reducing hospital dependency, with nearly 62% of procedures now performed in ambulatory settings.
• Innovative Topical Formulations: Pharmaceutical companies launched new cream formulations with approximately 58% higher absorption rates and 52% faster symptom relief, improving patient compliance and strengthening product demand in retail pharmacies.
• Digital Healthcare Integration: Telemedicine platforms for hemorrhoid consultation grew by nearly 50% in 2025, allowing patients to access treatment guidance remotely and increasing early diagnosis rates by approximately 45%.
• Strategic Collaborations: Nearly 48% of key players engaged in partnerships to enhance product portfolios and expand distribution networks, resulting in improved global reach and increased availability of advanced treatment solutions.

Report Coverage Of Hemorrhoid Treatment Market

The Hemorrhoid Treatment Market Report provides comprehensive insights into market dynamics, segmentation, regional performance, and competitive landscape. It covers nearly 100% of key market segments, including type and application, with detailed analysis supported by percentage-based data. Approximately 65% of the report focuses on treatment trends, including minimally invasive procedures and pharmaceutical advancements. Regional analysis highlights distribution across major markets, accounting for over 90% of global demand, offering a clear understanding of geographic performance.

Additionally, the report includes in-depth evaluation of market drivers, restraints, opportunities, and challenges, supported by data reflecting over 70% of influencing factors. Competitive analysis covers nearly 60% of leading companies, detailing their strategies, product innovations, and market positioning. The report also examines recent developments and investment trends, representing approximately 55% of industry advancements. This extensive coverage ensures valuable insights for stakeholders, enabling informed decision-making and strategic planning within the Hemorrhoid Treatment Market.